✦ LIBER ✦

bcr/abl-Negative, Classic Myeloproliferative Disorders: Diagnosis and Treatment

✍ Scribed by Tefferi, Ayalew; Barbui, Tiziano

Book ID: 123593977
Publisher: Mayo Clinic
Year: 2005
Tongue: English
Weight: 169 KB
Volume: 80
Category: Article
ISSN: 0025-6196
DOI: 10.4065/80.9.1220

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Life expectancy and prognostic factors i

Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders

✍ Cervantes, F; Passamonti, F; Barosi, G 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 205 KB

BCR-ABL1—Negative Myeloproliferative Neo

BCR-ABL1—Negative Myeloproliferative Neoplasms: A Review of Molecular Biology, Diagnosis, and Treatment

✍ Erik Vakil; Ayalew Tefferi 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 451 KB

BCR-ABL1-positive CML and BCR-ABL1-negat

BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: some common and contrasting features

✍ Cross, N C P; Daley, G Q; Green, A R; Hughes, T P; Jamieson, C; Manley, P; Mugha 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 260 KB

New Insights into the Molecular Pathogen

New Insights into the Molecular Pathogenesis of Bcr-Abl–Negative Myeloproliferative Disorders

✍ Plo, Isabelle; Chaligné, Ronan; James, Chloé; Vainchenker, William 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 565 KB

Mutational analysis in BCR-ABL -negative

Mutational analysis in BCR-ABL -negative classic myeloproliferative neoplasms: impact on prognosis and therapeutic choices

✍ Tefferi, Ayalew 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 201 KB

Genetic analysis of chromosome 13 deleti

Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders

✍ Cristina Pastore; Josep Nomdedeu; Gisella Volpe; Angelo Guerrasio; Giovanna Rege 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

## Abstract Chromosomal deletions of band 13q14 occur recurrently in __BCR/ABL__ negative chronic myeloproliferative disorders (CMPD), including myelosclerosis with myeloid metaplasia (MMM), polycythemia vera (PV), essential thrombocythemia (ET), juvenile chronic myeloid leukemia (JCML), and the so